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While interferons help kill virally infected cells, they can also promote systemic immune responses in distant
tissues. In this issue of Cell Host & Microbe, Sun et al. (2015) demonstrate that type I interferon induces
intestinal epithelial proliferation. Thismay helpmaintain a healthy gut and promote recovery from viral gastro-
enteritis.Let us view the human immune system as
a national department of defense. At its
best, the body’s defense system utilizes
a multifaceted approach to fend off
enemies by identifying and disarming evil-
doers, building a strong army, and main-
taining secure borders. When interferons
were first described in the 1950s, they
were noted to promote immunity by
disabling cells in the direct vicinity of vir-
ally infected cells. By inducing the release
of exosomes to neutralize viruses and
triggering apoptosis of host cells, inter-
ferons can coordinate the assassination
of infected cells and create a perimeter
around infected areas (Li et al., 2013).
Thus, in the defense system, interferons
became well known for their role in killing
cells at the primary site of infection.
Recently, however, interferons have also
been shown to activate systemic immune
responses at sites distant from the infec-
tion itself.
Indeed, new research indicates that
interferons also have a role in building
immunological armies and securing the
body’s defensive borders.
In recent experiments, types I and II
IFN have been shown to affect prolifera-
tion of hematopoietic stem cells (HSCs)
(Essers et al., 2009; Baldridge et al.,
2010). IFN stimulation leads to increased
proliferation and differentiation of he-
matopoietic progenitors, suggesting a
role for stem cells in building the army
of immune cells needed to respond to
microbial invasion and injury (Matatall
et al., 2014). Unlike the antiviral state in
the affected tissue, these interferon re-
sponses occur remote from the site of
infection and are not associated with
immediate apoptosis or induction of cyto-
toxic responses.
In this issue of Cell Host & Microbe,
Stappenbeck and colleagues report yet6 Cell Host & Microbe 17, January 14, 2015 ªanother mechanism of IFN-mediated im-
munity at the systemic level: strength-
ening borders in the intestinal epithelium
(Sun et al., 2015; summarized in Figure 1).
Trillions of microbiota colonize our gut,
and the intestinal lining is a critical barrier
to infection. Sun et al. (2015) show that
some types of viral infection potentiate in-
testinal epithelial proliferation and repair,
even if the infection is located distant
from the gut. Further, using mice with
chronically elevated IFN levels (Irgm1/
knockout mice), Sun et al. (2015) find
that type I IFNs play a vital role in the
repair of epithelial injury by stimulating
proliferation of cells in the epithelial tissue,
including stem cells at the crypt base and
transit-amplifying cells in the upper crypt.
The work by Sun et al. (2015) under-
scores the growing appreciation of direct
interactions between the human body
and its microbiome to maintain health.
The mammalian body has evolved along-
side microbes for millions of years, result-
ing in a complex ecosystem in which the
health of the host depends on microbes
for nutritional factors such as vitamin K
and maintenance of other physiologic
processes. As early as the 1960s, studies
described abnormalities such as gross
and microscopic intestinal differences,
slow epithelial turnover, and altered
immune responses to antigenic stimuli
in germ-free mice (Gordon and Pesti,
1971). Fecal transplants or defined
microbe introduction to these mice al-
lowed normalization of at least some of
these aberrations. Similar abnormalities
have been described in antibiotic-treated
mice, further supporting the role of
microbes in maintenance of the basal
or physiologic inflammatory state. In a
recent report by Kernbauer et al. (2014),
epithelial turnover was found to be
impaired in wild-type (WT) mice treated2015 Elsevier Inc.with antibiotics, with reversal of the pheno-
type upon infection with murine norovirus
in an IFNa-dependent manner. Interest-
ingly, Ifnar1/ single knockout mice did
not exhibit impaired wound healing or
notably aberrant epithelial proliferation at
baseline; however, antibiotic treatment of
Ifnar1/ mice did lead to abnormal intes-
tinal morphology, suggesting that other in-
flammatory mediators, likely derived from
the interplay between intestinal flora and
the mucosa, may also be involved in
enhancing epithelial turnover.
Sun et al. (2015) show that IFNa sensing
is required on macrophages, but not
epithelial cells for enhanced wound
repair. Notably, in the hematopoietic sys-
tem, macrophages have been reported
to serve an anti-inflammatory role to pro-
tect stem cell self-renewal (Winkler et al.,
2010). The work by Sun et al. (2015) sug-
gests that similar mechanisms may be at
play in the intestine, with macrophages
serving a sentinel role to promote intesti-
nal turnover in the setting of systemic
infection. Using coculture techniques,
macrophages were shown to signal to
epithelial cells in trans by release of apoli-
poprotein Apol9a, induced during type I
IFN responses, and induction of ERK acti-
vation. While WNT signaling has been
the major focus of study in understanding
intestinal epithelial turnover and prolifera-
tion, ERK signaling has also been shown
to promote cell proliferation in the intesti-
nal epithelium. Although crosstalk be-
tween the ERK and WNT pathways has
been reported in othermodels of epithelial
repair, Apol9a did not strengthen or sub-
stitute for WNT signaling in this injury
model.
As important as inflammation is for
pathogen clearance and healing, too
much inflammation is harmful, as evi-
denced by autoimmune disorders and
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Figure 1. Summary of the Process of Intestinal Epithelial Response to Injury as Described by
Sun et al. (2015)
Type I IFN produced by intestinal epithelial cell infected by virus, or by other stimulus on tissue, in turn
stimulates macrophage to produce Apol9a. Apol9a is released from macrophage and may be directly
taken up by intestinal epithelial progenitor or cause Apol9a production by the progenitor cell by other
means. Downstream activation of the ERK pathway occurs, leading to increased proliferation of the intes-
tinal epithelial progenitor cells, allowing rapid regeneration of the intestinal epithelium in response to injury.
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distress syndrome. Use of the Irgm1-defi-
cient mice to model an inflammatory state
highlights both the power and the poten-
tial weaknesses of this model. We
previously reported that Irgm1-deficient
mice have high IFNg levels (King et al.,
2011), whereas the Sun et al. (2015)
study reports elevated IFNa. In mice with
abnormal macrophage function, these
differences may reflect inconsistencies
in environmental housing conditions and
host/microbe interactions, which in turn
may impact a variety of phenotypes.
These differences demonstrate the need
for new standards for microbial coloniza-
tion as the field of microbiome/host inter-
actions expands. Why the Irgm1-deficient
mice do not display signs of autoimmune
disease also presents a conundrum forfurther study. In the hematopoietic sys-
tem, proliferative responses to IFN are
carefully regulated to conserve the stem
cell pool and/or reduce the risk of malig-
nancy-inducing DNA copy errors (King
et al., 2011; Pietras et al., 2014). Further
investigation of these regulatory mecha-
nisms is likely to yield important insights
into how to prevent and treat autoimmune
conditions.
Despite these caveats, use of the Irgm1
model has enabled characterization of
the role of IFNa signaling in intestinal
epithelial homeostasis and wound repair.
Amazingly, Irgm1-deficient mice showed
more rapid wound healing after chemi-
cally induced ulcer formation in the intes-
tine. While Sun et al. (2015) have identified
Apol9a as an IFN-inducible mediator of in-
testinal epithelial proliferation, it remainsCell Host & Microbeto be determined if exogenous expression
of Apol9a at sites of injury can accelerate
wound healing. This work would enable
the exciting opportunity to explore the
therapeutic potential of Apol9a tomediate
wound healing without inducing the harm-
ful systemic effects of interferon-medi-
ated inflammation.
Sun et al. (2015) have made important
progress in clarifying the process by
which the intestinal epithelium responds
to viral infection and heals mucosal injury.
Interferons, though small and primitive,
continue to impress as coordinators of a
multifaceted defense system—powerfully
protecting the body through coordinated
responses ranging from targeted killings
to building armies and strengthening
borders.
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